Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Advertise | Contacts | Login 
  Users Online: 432 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
CASE REPORT
Year : 2018  |  Volume : 8  |  Issue : 3  |  Page : 114-116

Human menopausal gonadotropin-induced bioprosthetic valve thrombosis


Department of Cardiology, Prince Sultan Cardiac Center Qassim, King Fahad Specialist Hospital, Buraydah, Al-Qassim Province, Saudi Arabia

Correspondence Address:
Dr. Rami Mahmood Abazid
Department of Cardiology, Prince Sultan Cardiac Center Qassim, Noninvasive Cardiac Imaging, Buryadah, Qassim
Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ajm.AJM_83_18

Rights and Permissions

Bioprosthetic valve thrombosis (BPVT) is a rare but potentially life-threatening complication. Human menopausal gonadotropin (hMG) is commonly used for ovulation induction and has been associated with arterial and venous thrombosis. We reported a case of BPVT related to in vitro fertilization in a 39-year-old female, who underwent redo mitral valve replacement. To the best of our knowledge, this is the first case of hMG-induced BPVT in a young female patient.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1017    
    Printed22    
    Emailed0    
    PDF Downloaded72    
    Comments [Add]    
    Cited by others 1    

Recommend this journal